SCC Quarterly Meeting: Leveraging Social Science for Social Progress on Psychedelics (Abel Gustafson, PhD & Matt Goldberg, PhD)
About Psychedelic therapies are becoming more visible in both clinical research and public discourse, and patients often look to cannabis clinicians for trustworthy, evidence-based insights. While cannabis and psychedelics are distinct modalities, they share overlapping patient populations, therapeutic goals, and sociopolitical challenges. As these treatments gain momentum, clinicians must be prepared to discuss them responsibly,...